Millions of Australians at risk of heart disease
Data from the Australian Bureau of Statistics (ABS) suggests that 13 million people have at least three risk factors for developing cardiovascular disease (CVD).1 A...
Post-partum president
Chelsea Felkai MPS usually balances a busy life of university teaching, PhD study and community pharmacy locum shifts in Newcastle, NSW.
SSRIs for mild cognitive impairment to Alzheimer’s disease
Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment?
An estimated 10% of people...
COVID-19 rollout strategy recalibrated
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.
Action needed to improve medicine safety in disability care
Barriers to medicine safety show a health system failing to properly support Australians with a disability, a new report from PSA reveals.
How psilocybin can help terminally ill patients
Psilocybin, a psychoactive compound found in ‘magic mushrooms’, is being trialled in the treatment of terminally ill patients to reduce symptoms of depression and...
